Understanding Death in Children With Epilepsy

Elizabeth J Donner1, Peter Camfield2, Linda Brooks3

  • 1Division of Neurology, Department of Paediatrics, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.

Pediatric Neurology
|March 1, 2017
PubMed

Insights

Children with epilepsy face a tenfold higher risk of death, often linked to underlying conditions rather than seizures. Sudden Unexpected Death in Epilepsy (SUDEP) is rare in childhood but preventable by managing seizure frequency.

Area of Science:

  • Pediatric Neurology
  • Epilepsy Research
  • Childhood Mortality

Background:

  • Childhood epilepsy carries a significantly elevated mortality risk compared to the general population.
  • Most deaths in children with epilepsy are associated with the underlying cause of the condition or neurological comorbidities, not seizures themselves.
  • Sudden Unexpected Death in Epilepsy (SUDEP) is the most frequent cause of seizure-related mortality, though uncommon in childhood.

Purpose of the Study:

  • To review the risk of death in children with epilepsy.
  • To inform healthcare providers on discussing mortality risks with families.
  • To guide healthcare professionals in supporting families after a child's death from epilepsy.

Main Methods:

  • Literature review on childhood epilepsy mortality.
  • Analysis of SUDEP causes and risk factors.
  • Discussion of communication strategies and family support.

Main Results:

  • The overall mortality risk for children with epilepsy is approximately ten times higher than in the general population.
  • Risk of premature death is similar to the general population for children without neurological comorbidities.
  • SUDEP risk is linked to drug-resistant epilepsy and frequent generalized tonic-clonic seizures, with prevention focused on seizure frequency reduction.

Conclusions:

  • Effective SUDEP prevention involves reducing seizure frequency.
  • Open communication about mortality risks between healthcare providers and families is crucial post-diagnosis.
  • Healthcare professionals play a vital role in supporting grieving families.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
575
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405